News Daily


Men's Weekly

News from Asia

  • Written by Media Outreach
SEATTLE, USA - News Direct - 04 January 2024 - AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC Inc.’s Yokohama Technical Center in Japan. The new site is a part of the CDMO’s strategic growth strategy to create more high-quality pharmaceutical development and manufacturing services in the Asia region that can help meet the global demand for biologics and advanced therapy medicinal products (ATMPs). The facility is expected to be operational in 2026.

The new AGC Biologics Yokohama facility will offer pre-clinical through commercial services for mammalian-based protein biologics, cell therapies and messenger RNA (mRNA). The site will house multiple 2,000L single-use bioreactors and several 4,000L or larger reactors for mammalian cell culture services, making it one of Japan’s largest* sites for mammalian-based manufacturing capacity once complete. (*AGC estimates)

AGC Biologics is building this facility thanks to a grant from the Japanese Ministry of Economy, Trade and Industry (METI) as part of the ministry’s initiative to develop biopharmaceutical manufacturing sites to strengthen vaccine production in the region (announced in October 2022). The total investment for the AGC Biologics Yokohama site is expected to be approximately 50 billion Japanese yen ($350,500,000 USD) and once fully operational it will employ 400 people.

“With an increased demand in this region for high-quality partners that have a history of clinical and commercial biopharmaceutical manufacturing, we are making this investment to offer developers the services they need, and strengthen our global CDMO network,” said Patricio Massera, Chief Executive Officer, AGC Biologics. “The new Yokohama facility will be a central location for innovators in Japan and across the Asia Pacific, offering scientific expertise, technical flexibility and needed services to support development and manufacturing at every critical stage.”

The Yokohama facility is expected to significantly contribute to the needs of regional and global developers seeking biopharmaceutical development and manufacturing capabilities, in addition to further maximizing operational and supply chain efficiencies across AGC Biologics' global network. The company currently operates one site in the region, its Chiba facility, offering mammalian expression and microbial fermentation services.

AGC Biologics is a part of AGC Inc.’s Life Science Company. The Life Science company runs ten different facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients and agrochemicals.

To learn more about AGC Biologics’ global network of services for protein biologics and cell and gene therapies, please visit www.agcbio.com.

Hashtag: #AGCBiologics

The issuer is solely responsible for the content of this announcement.

Read more

Top Electrical Safety Tips from Inner West Sydney Electricians

While it may not be the most exciting subject to discuss, having an electrically safe home is definitely one of the most critical. Knowing the basics could help you avoid accidents and ensure your home remains in good condition, whether... Read more

When to Escalate a Debt Recovery Matter to Legal Action

Knowing when to transition from informal debt collection efforts to formal legal proceedings is a decision that many creditors find difficult to navigate. Acting too early can damage commercial relationships, while waiting too long can reduce the likelihood of recovery... Read more

Why Slurry Hose Systems Are Essential for Handling Abrasive Industrial Materials

Transporting abrasive mixtures is a common challenge in industries such as mining, dredging, and construction. These mixtures, known as slurry, consist of solid particles suspended in water or other liquids. Moving slurry through pipelines requires specialised equipment that can withstand... Read more

Why Choosing the Right Dental Clinic Matters for Long Term Oral Health

Maintaining good oral health requires regular checkups, preventive care, and professional treatment when needed. Visiting a trusted Dental Clinic plays a vital role in keeping teeth and gums healthy while preventing more serious dental problems in the future. Many people only... Read more

Is Deep Plane Facelift Safe in Thailand?

When you ask whether a deep plane facelift is safe in Thailand, you’re really asking: “Can I get high-quality surgical care with strong safety standards and reliable follow-up while I’m traveling?” That’s a smart question. But the country name alone... Read more

Why Cloud Services Are Now Essential for Business Growth and Security

In today’s fast-moving digital environment, understanding how cloud services support long-term stability has become a priority for businesses across Australia. As expectations shift and workplaces adopt more flexible models, organisations are turning to cloud services to keep systems running smoothly... Read more